| __timestamp | BeiGene, Ltd. | Telix Pharmaceuticals Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 21862000 | 22622695 |
| Thursday, January 1, 2015 | 58250000 | 24863028 |
| Friday, January 1, 2016 | 98033000 | 21351001 |
| Sunday, January 1, 2017 | 273992000 | 53837297 |
| Monday, January 1, 2018 | 707710000 | 16080096 |
| Tuesday, January 1, 2019 | 998528000 | 18525736 |
| Wednesday, January 1, 2020 | 1365534000 | 2024000 |
| Friday, January 1, 2021 | 1624145000 | 2548000 |
| Saturday, January 1, 2022 | 1926983000 | 61556000 |
| Sunday, January 1, 2023 | 379920000 | 188157000 |
Data in motion
In the ever-evolving landscape of the pharmaceutical industry, understanding cost dynamics is crucial. Over the past decade, BeiGene, Ltd. and Telix Pharmaceuticals Limited have shown contrasting trends in their cost of revenue. BeiGene, Ltd. has experienced a staggering increase, with costs rising from approximately $22 million in 2014 to a peak of nearly $1.93 billion in 2022, before a notable drop in 2023. This represents an increase of over 8,600% at its peak. In contrast, Telix Pharmaceuticals Limited maintained a more stable trajectory, with costs fluctuating modestly, peaking at around $188 million in 2023. This data highlights BeiGene's aggressive expansion and investment in research and development, while Telix's steadier approach suggests a focus on sustainable growth. These insights provide a window into the strategic priorities of these two pharmaceutical giants.
Cost Insights: Breaking Down Novo Nordisk A/S and BeiGene, Ltd.'s Expenses
Cost of Revenue Trends: Sanofi vs BeiGene, Ltd.
Cost Insights: Breaking Down Sanofi and Telix Pharmaceuticals Limited's Expenses
Cost of Revenue Trends: Bristol-Myers Squibb Company vs BeiGene, Ltd.
BeiGene, Ltd. vs Intra-Cellular Therapies, Inc.: Efficiency in Cost of Revenue Explored
BeiGene, Ltd. vs Pharming Group N.V.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: BeiGene, Ltd. vs Cytokinetics, Incorporated
Cost Insights: Breaking Down BeiGene, Ltd. and Dyne Therapeutics, Inc.'s Expenses
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Telix Pharmaceuticals Limited
Cost of Revenue: Key Insights for Exelixis, Inc. and Telix Pharmaceuticals Limited
Comparing Cost of Revenue Efficiency: Cytokinetics, Incorporated vs Telix Pharmaceuticals Limited
Telix Pharmaceuticals Limited vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored